← SynDRA
VALDECOXIB
SynDRA canonical compound SYN0002275 — structure-anchored drug synonym record
| Clinical phase | Withdrawn |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | PTGS2 |
|---|
| Mechanism of action | Cyclooxygenase inhibitor |
|---|
All known targets
- PTGS2
- CA12
- CA
- CYP2C19
- mtcA1
- ca1
- SLC6A2
- PTGS1
- NCE103
- MT-CO2
- MT-CO1
- HTR2B
Mechanisms of action (all sources)
- Cyclooxygenase inhibitor
- PTGS2 INHIBITOR
- CA12 INHIBITOR
Drug classes
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antirheumatic Agents
- Cyclooxygenase 2 Inhibitors
- Cyclooxygenase Inhibitors
- Enzyme Inhibitors
- Peripheral Nervous System Agents
- Sensory System Agents
ATC classes
- M01A · ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
Cross-references
Synonyms
- valecoxib
- Valdyn
- NSC-759846
- SC-65872
- Bextra
- Valdyn (previously kudeq)
- COX
- Kudeq
- Pfizer brand of valdecoxib
- Valdecoxib [USAN]
- ND-0214
- YM-974
- Valdecoxib (USAN/INN)
- P-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide
- Benzenesulfonamide, 4-(5-methyl-3-phenyl-4-isoxazolyl)-(9CI)
- 4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide
- 4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide
- 4-(5-methyl-3-phenyl-4-isoxazolyl) benzenesulfonamide
- 4-(5-methyl-3-phenyl-isoxazol-4-yl)benzenesulfonamide
- 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide
- 4-(Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide
- SC 65872
- valdecoxibum
- p-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide
- NSC 759846
- DTXCID4024226
- CHEBI:63634
- 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide
- RefChem:56405
- M01AH03
- Benzenesulfonamide, 4-(5-methyl-3-phenyl-4-isoxazolyl)-
- MFCD00950568
- 4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzene-1-sulfonamide
- Valdecoxib-13C2, 15N
- NCGC00095129-01
- Valecoxib
- SMR000466327
- CAS-181695-72-7
Look up VALDECOXIB in the interactive SynDRA portal →